Take our Members' Survey
Have your say on what you want to see in 2023
We've had a great first year of the Lupus Forum, and would love to hear your feedback. What do you find useful, what would you like to see more of, what new topics can we cover that are relevant to your practice?
Lupkynis approved in the UK for adults with active Lupus Nephritis
Decision by MHRA on 5th December
Aurinia Pharmaceuticals announced the MHRA marketing authorisation of Lupkynis (voclosporin) to treat adults with active lupus nephritis based on the Phase 3 AURORA 1 trial and the AURORA 2 continuation study. You can find information on voclosporin in our Therapy Essentials slide deck
Litifilimab author interview podcast now available
Victoria Werth and Richard Furie discuss the results from the Phase 2 LILAC study of litifilimab in CLE and SLE